NU 623 unit 6 quiz 3 Questions and Answers
Study online at https://quizlet.com/_i391hb
1. Which of the following characteristics applies to type 1 diabetes mellitus
(DM)?
A. Significant hyperglycemia and ketoacidosis result from lack of insulin
B. This condition is commonly diagnosed on routine examination or work-up
for other health problems
C. Initial response to oral sulfonylureas is usually favorable
D. Insulin resistance (IR) is a significant part of the disease.
(Ch. 11 Fitzgerald): A
2. Which of the following characteristics applies to type 2 DM?
A. Major risk factors are heredity and obesity
B. Pear-shaped body type is commonly found.
C. Exogenous insulin is needed for control of disease
D. Physical activity enhances IR.
(Ch. 11 Fitzgerald): A
3. You consider prescribing insulin glargine (Lantus) because of its:
A. extended duration of action
B. rapid onset of action
C. ability to prevent diabetic end-organ damage
D. ability to preserve pancreatic function
(Ch. 11 Fitzgerald): A
4. After use, the onset of action of lispro (Humalog) occurs in:
A. less than 30 min
B approximately 1 hour
C. 1 to 2 hours
D. 3 to 4 hours
(Ch. 11 Fitzgerald): A
5. Which of the following medications should be used with caution in a person
with suspected or known sulfa allergy?
, NU 623 unit 6 quiz 3 Questions and Answers
Study online at https://quizlet.com/_i391hb
A. metformin
B. glyburide
C. rosiglitazone
D. NPH insulin
(Ch. 11 Fitzgerald): b
6. The mechanism of action of metormin (Glucophage) is as:
A. an insulin-production enhancer
B. a product virtuallyidentical in action to solfonylureas
C. a drug that increases insulin action in the peripheral tissues and reduces
hepatic glucose production
D. a facilitator of renal glucose excretion.
(Ch. 11 Fitzgerald): c
7. Generally testing for type 2 DM in asymptomatic, undiagnosed individuals
older than 45 years should be conducted every _____.
A. year
B. 3 years
C. 5 years
D. 10 years
(Ch. 11 Fitzgerald): B
8. You are seeing 17 year old Cynthia. As part of the visit, you consider her risk
factors for type 2 DM would likely include all of the following except:
A. obesity
B. Native American ancestry
C. family history of type 1 DM
D. personal history of polycystic ovary syndrome: c
9. Criteria for the dianosis of type 2 DM include:
A. classic symptoms regardless of fasting plasma glucose measurement.
B. plasma glucose level of 126 mg/dL & (7mmol/L) as a random measurement
C. a 2 hour glucose measurement of 156 mg/dL (8.6 mmol/L) after a 75 g
, NU 623 unit 6 quiz 3 Questions and Answers
Study online at https://quizlet.com/_i391hb
anhydrous glucose load.
D. a plasma glucose level of 126 mg/dL (7mmol/L) or greater after an 8 hour or
greater fast on more than one occasion
(Ch. 11 Fitzgerald): D
10. The mechanism of action of pioglitazone is as:
A. an insulin-production enhancer
B. a reducer of pancreatic glucose output.
C. an insulin sensitizer
D. a facilitator of renal glucose excretion
(Ch. 11 Fitzgerald): C
11. Which of the following should be the goal measurement in treating a person
with DM and hypertension?
A. blood pressure less than 140 mm Hg systolic and less than 90 mm Hg
diastolic
B. hemoglobin A1c equal to or greater than 7%
C. triglyceride 200 to 300 mg/dL (11.1 to 16.6 mmol/L)
D. high-density lipoprotein (HDL) 35 to 40 mg/dL (0.9 to 1.03 mmol/L)
(Ch. 11 Fitzgerald): A
12. In caring for a patient with DM, microalbuminuria measurement should be
obtained:
A. annually if urine protein is present
B. periodically in relationship to glycemia control
C. yearly
D. with each office visit related to DM
(Ch. 11 Fitzgerald): C
13. The mechanism of action of sulfonylureas is as:
A. an antagonist of insulin receptor site activity
B. a product that enhances insulin release
, NU 623 unit 6 quiz 3 Questions and Answers
Study online at https://quizlet.com/_i391hb
C. a facilitator of renal glucose excretion
D. an agent that can reduce hepatic glucose production
(Ch. 11 Fitzgerald): B
14. When caring for a patient with DM, hypertension and persistent proteinuria,
the NP prioritizes the choice of antihypertension and prescribes:
CA. furosemide
B. methyldopa
C. fosinopril
D. nefedipine
(Ch. 11 Fitzgerald): C
15. Clinical presentation of type 1 DM usually includes all of the following ex-
cept:
A. report of recent unintended weight gain
B. ketosis
C. thirst
D. polyphagia
(Ch. 11 Fitzgerald): A
16. Which of the following should be periodically monitored with the use of
biguanide?
A. creatine kinase (CK)
B. alkaline phosphatase (ALP)
C. alanine aminotransferase (ALT)
D. creatinine (Cr)
(Ch. 11 Fitzgerald): d
17. Which of the following should be periodically monitored with the use of
thiazolidinedione?
A. CK
B. ALP
Study online at https://quizlet.com/_i391hb
1. Which of the following characteristics applies to type 1 diabetes mellitus
(DM)?
A. Significant hyperglycemia and ketoacidosis result from lack of insulin
B. This condition is commonly diagnosed on routine examination or work-up
for other health problems
C. Initial response to oral sulfonylureas is usually favorable
D. Insulin resistance (IR) is a significant part of the disease.
(Ch. 11 Fitzgerald): A
2. Which of the following characteristics applies to type 2 DM?
A. Major risk factors are heredity and obesity
B. Pear-shaped body type is commonly found.
C. Exogenous insulin is needed for control of disease
D. Physical activity enhances IR.
(Ch. 11 Fitzgerald): A
3. You consider prescribing insulin glargine (Lantus) because of its:
A. extended duration of action
B. rapid onset of action
C. ability to prevent diabetic end-organ damage
D. ability to preserve pancreatic function
(Ch. 11 Fitzgerald): A
4. After use, the onset of action of lispro (Humalog) occurs in:
A. less than 30 min
B approximately 1 hour
C. 1 to 2 hours
D. 3 to 4 hours
(Ch. 11 Fitzgerald): A
5. Which of the following medications should be used with caution in a person
with suspected or known sulfa allergy?
, NU 623 unit 6 quiz 3 Questions and Answers
Study online at https://quizlet.com/_i391hb
A. metformin
B. glyburide
C. rosiglitazone
D. NPH insulin
(Ch. 11 Fitzgerald): b
6. The mechanism of action of metormin (Glucophage) is as:
A. an insulin-production enhancer
B. a product virtuallyidentical in action to solfonylureas
C. a drug that increases insulin action in the peripheral tissues and reduces
hepatic glucose production
D. a facilitator of renal glucose excretion.
(Ch. 11 Fitzgerald): c
7. Generally testing for type 2 DM in asymptomatic, undiagnosed individuals
older than 45 years should be conducted every _____.
A. year
B. 3 years
C. 5 years
D. 10 years
(Ch. 11 Fitzgerald): B
8. You are seeing 17 year old Cynthia. As part of the visit, you consider her risk
factors for type 2 DM would likely include all of the following except:
A. obesity
B. Native American ancestry
C. family history of type 1 DM
D. personal history of polycystic ovary syndrome: c
9. Criteria for the dianosis of type 2 DM include:
A. classic symptoms regardless of fasting plasma glucose measurement.
B. plasma glucose level of 126 mg/dL & (7mmol/L) as a random measurement
C. a 2 hour glucose measurement of 156 mg/dL (8.6 mmol/L) after a 75 g
, NU 623 unit 6 quiz 3 Questions and Answers
Study online at https://quizlet.com/_i391hb
anhydrous glucose load.
D. a plasma glucose level of 126 mg/dL (7mmol/L) or greater after an 8 hour or
greater fast on more than one occasion
(Ch. 11 Fitzgerald): D
10. The mechanism of action of pioglitazone is as:
A. an insulin-production enhancer
B. a reducer of pancreatic glucose output.
C. an insulin sensitizer
D. a facilitator of renal glucose excretion
(Ch. 11 Fitzgerald): C
11. Which of the following should be the goal measurement in treating a person
with DM and hypertension?
A. blood pressure less than 140 mm Hg systolic and less than 90 mm Hg
diastolic
B. hemoglobin A1c equal to or greater than 7%
C. triglyceride 200 to 300 mg/dL (11.1 to 16.6 mmol/L)
D. high-density lipoprotein (HDL) 35 to 40 mg/dL (0.9 to 1.03 mmol/L)
(Ch. 11 Fitzgerald): A
12. In caring for a patient with DM, microalbuminuria measurement should be
obtained:
A. annually if urine protein is present
B. periodically in relationship to glycemia control
C. yearly
D. with each office visit related to DM
(Ch. 11 Fitzgerald): C
13. The mechanism of action of sulfonylureas is as:
A. an antagonist of insulin receptor site activity
B. a product that enhances insulin release
, NU 623 unit 6 quiz 3 Questions and Answers
Study online at https://quizlet.com/_i391hb
C. a facilitator of renal glucose excretion
D. an agent that can reduce hepatic glucose production
(Ch. 11 Fitzgerald): B
14. When caring for a patient with DM, hypertension and persistent proteinuria,
the NP prioritizes the choice of antihypertension and prescribes:
CA. furosemide
B. methyldopa
C. fosinopril
D. nefedipine
(Ch. 11 Fitzgerald): C
15. Clinical presentation of type 1 DM usually includes all of the following ex-
cept:
A. report of recent unintended weight gain
B. ketosis
C. thirst
D. polyphagia
(Ch. 11 Fitzgerald): A
16. Which of the following should be periodically monitored with the use of
biguanide?
A. creatine kinase (CK)
B. alkaline phosphatase (ALP)
C. alanine aminotransferase (ALT)
D. creatinine (Cr)
(Ch. 11 Fitzgerald): d
17. Which of the following should be periodically monitored with the use of
thiazolidinedione?
A. CK
B. ALP
